Classys expects global device sales to surpass fifty thousand units

Classys Inc. announced on August 25, 2026, that its cumulative global device sales are expected to surpass 50,000 units, a milestone that points to more competitive procurement options for clinic owners looking outside traditional Western brands. At the end of June 2026, the company's global footprint included more than 22,000 installed High-Intensity Focused Ultrasound (HIFU) systems, 4,000 monopolar radiofrequency (MRF) systems, and 6,000 microneedling radiofrequency (MNRF) devices. Financially, Classys reported consolidated revenue of KRW 192.7 billion for the first half of 2026, up 20% year-over-year, supported by a 50.8% standalone operating margin. This growth is driven by international markets, with export sales rising 29% and new European expansion into countries like the UK, Sweden, and the Netherlands. For practices managing device overhead, this scaling volume, alongside a 52.7% rise in consumables revenue compared to the first half of 2024, means Classys is securing the capital needed to support its next-generation Quadessy and Viclara platforms. The practical implication is a shifting market where high-performance energy devices are becoming more globally integrated, challenging the pricing power of legacy manufacturers.

Source: Barchart, https://www.barchart.com/story/news/28246376/classys-nears-50000-devices-sold-globally-as-full-lineup-growth-accelerates